🔎 Trials Near Me

Akèy › Amiloidoz › Kalifòni › San Francisco

Etid klinik pou Amiloidoz nan San Francisco, CA

4 etid pou Amiloidoz ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Ap rekriteFaz 1
  • University of California San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05652335

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Ap rekriteEtid obsèvasyon
  • Research Site, San Francisco
  • Research Site, San Francisco
Laj 18 a 130 · Tout sèks · Mizajou Sep 23, 2026 · NCT06465810

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Ap rekriteFaz 3
  • University of California, San Francisco (UCSF), San Francisco
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

Ap rekriteFaz 1/2
  • Research Site, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07081646

Etid Amiloidoz nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.